MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Onconova Therapeutics Company Profile (NASDAQ:ONTX)

Consensus Ratings for Onconova Therapeutics (NASDAQ:ONTX) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $3.67 (824.11% upside)

Analysts' Ratings History for Onconova Therapeutics (NASDAQ:ONTX)
Show:
DateFirmActionRatingPrice TargetActions
3/29/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2015Piper JaffrayReiterated RatingOverweight$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015Janney Montgomery ScottReiterated RatingNeutral -> Fair Value$3.00 -> $1.52View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha